Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways - Wikidata - awgldk - TriplyDB

Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways

Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways

http://www.wikidata.org/entity/Q41869781

about

Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease.V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea-pig model of allergic asthma.Inhaled muscarinic antagonists for respiratory diseases: a review of patents and current developments (2006 - 2010).Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease.Long-acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease.Emerging drugs for chronic obstructive pulmonary disease.Inhaled glycopyrronium bromide: a review of its use in patients with moderate to severe chronic obstructive pulmonary disease.Benchmarking of Human Dose Prediction for Inhaled Medicines from Preclinical In Vivo Data.A comparative study of the beneficial effects of ipratropium and beclomethasone against insulin-induced tracheal tissue contraction in a guinea pig model.Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease.Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators.

P2860

Q35135970-C654C252-3F6F-409A-852B-63AB05830268 Q35710238-A729870A-0C37-4B1C-BAB7-EC75451B905D Q36024959-F61FAE8A-0EEB-4B43-8A55-C5B66F24436E Q37894102-F4FA033D-B479-4B20-9339-F19441FD7869 Q37937554-50E0AD38-3DA0-4B66-8422-D62C0FF3AD76 Q37960070-6663B83E-F6E9-4D25-A827-8E5B333AE4CF Q37984088-99F2CFF9-23C1-4D7B-8B5B-34DF389161FC Q38107178-856D1598-9957-4DAE-BD62-112A22FF8C1F Q38690068-C41F0024-7B14-4F81-929A-EC35FEDD0919 Q42756765-CD6DFDDA-ED4F-45F6-B297-1BF802B549E4 Q47102804-797BBB36-0F05-4896-9FDC-AC1B5684F342 Q47669469-0752BA7F-06CB-43E1-B6E0-BD8C14C04D65

P2860

Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways

http://www.wikidata.org/entity/Q41869781

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Pharmacological assessment of ...... n guinea-pig and human airways

@en

type

label

Pharmacological assessment of ...... n guinea-pig and human airways

@en

prefLabel

Pharmacological assessment of ...... n guinea-pig and human airways

@en

P1433

Q41869781-914EBC64-44CC-4582-B023-C7624518AB95

P1476

Q41869781-D8C90E07-2FAB-430C-AD00-4FFC9FB3BB16

P2093

Q41869781-310EC6CC-5986-4111-A6E6-7A515CD13B96

Q41869781-380EC135-1106-4944-A025-086A4B4EBC7D

Q41869781-6C105E47-C1CF-421D-A3AA-0A06646B5E38

Q41869781-93BEA333-FF5D-44D3-B6C6-389C9904505E

Q41869781-97667A6B-23C9-4830-A7C2-49A49F99DB2E

Q41869781-A168B0F5-7F65-45E1-9BCD-CD875DE0E531

Q41869781-A1C645F0-B1AE-49AA-A71C-32D38CF8613F

Q41869781-AA8DDA93-650B-49B2-88E8-B510B73A2BCB

Q41869781-C456D90A-3208-4633-A1DD-91360169DD41

Q41869781-E3FE33DD-001B-4460-989E-4532E99929CC

P2860

Q41869781-0232F49A-530D-465B-AD03-F878CAC7FB76

Q41869781-06B87FC0-A897-4440-BE6D-AF1256813D48

Q41869781-15AD4194-202C-4780-BDA7-EC494E344796

Q41869781-18B35FA2-76BE-45BB-B4F5-B2F3CE843147

Q41869781-19781304-0E05-491B-8C0A-8420432441C9

Q41869781-2B32E1ED-8ACF-4396-8930-54767A33499C

Q41869781-2B70EE88-0542-4A8C-BF22-D5E6F1F443CA

Q41869781-2D4F38BF-5E9C-48B2-96E2-10D2E9894CC4

Q41869781-2EC6D552-A4D7-4586-8FDC-44517244B5E8

Q41869781-3980931D-D6BA-44BF-984C-4E06482BE794

P304

Q41869781-7AD517FB-1E1A-4EF6-A83A-7D4B74A1D14A

P31

Q41869781-E337E2F3-B5D2-439E-AA07-6D1248AE9E9E

P356

Q41869781-0C01586F-3CAF-4BF1-93C1-B69128A105F8

P407

Q41869781-93A355FC-E2F2-403E-BFEB-DADBEC43B2FE

P433

Q41869781-85D943C1-4CDC-4B50-AD06-7DE9414731ED

P478

Q41869781-D1DFF6A8-83C3-47B9-82AC-F6875B993EA4

P577

Q41869781-ED21E954-9A05-43D4-B687-3F35CEDFB4E8

P5875

Q41869781-33C90046-9797-4C3F-A61A-B5A3F55BB611

P698

Q41869781-FB089C25-EECA-4A4E-950A-2DAE30438EC5

P932

Q41869781-132E5343-E0B9-4B66-A93C-98D3CBE9BBFF

P356

P1433

British Journal of Pharmacology

P1476

Pharmacological assessment of ...... n guinea-pig and human airways

@en

P2093

Alberto Janni

http://www.w3.org/2001/XMLSchema#string

Franco Bassani

http://www.w3.org/2001/XMLSchema#string

Gino Villetti

http://www.w3.org/2001/XMLSchema#string

Marco Bergamaschi

http://www.w3.org/2001/XMLSchema#string

Maurizio Civelli

http://www.w3.org/2001/XMLSchema#string

Paolo M Gigli

http://www.w3.org/2001/XMLSchema#string

Pier Tonino Bolzoni

http://www.w3.org/2001/XMLSchema#string

Pierangelo Geppetti

http://www.w3.org/2001/XMLSchema#string

Riccardo Patacchini

http://www.w3.org/2001/XMLSchema#string

Selena Harrison

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways

Antisecretory agents in gastrointestinal obstruction.

Sialorrhea - therapeutic drug options.

Comparison of nebulized glycopyrrolate and metaproterenol in chronic obstructive pulmonary disease.

Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma.

New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.

The role of anticholinergics in chronic obstructive pulmonary disease.

Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.

Glycopyrrolate.

New therapies for chronic obstructive pulmonary disease.

P304

291-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0706724

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7213018

http://www.w3.org/2001/XMLSchema#string

P698

16565730

http://www.w3.org/2001/XMLSchema#string

P932

1751556

http://www.w3.org/2001/XMLSchema#string